BioMarin Pharmaceutical Profile

88.13
USD 0.38  0.43%
87.75Last Month High 95.13 
87.59Trading Day  High 89.95 

Acquisition or disposition of BioMarin Pharmaceutical securities by Robert Baffi

BioMarin Pharmaceutical Inc insider trading alert for acquisition or disposition of common stock by Robert Baffi, EVP Technical Operations, on October 13, 2017. This event was filed by Biomarin Pharmaceutical I with SEC on 2017-10-13. Statement of changes in beneficial ownership - SEC Form 4. Robert Baffi is currently serves as executive vp of technical operations of BioMarin Pharmaceutical [view details]   

BioMarin Pharmaceutical Summary

BioMarin Pharmaceutical Inc (BMRN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 2,158 people. BioMarin Pharmaceutical is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with current market capitalization of 15.38 B. BioMarin Pharmaceutical Inc conducts business under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 175.27 M outstanding shares of which 6.87 M shares are currently shorted by private and institutional investors with about 5.6 trading days to cover. BIOMARIN PHARMACE currently holds about 727.78 M in cash with (72.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.15.
Check BioMarin Pharmaceutical Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Rhenman Partners Asset Management AbCommon Shares179.9 K16.7 M
National Pension ServiceCommon Shares168.3 K15.6 M
Sonora Investment Management LlcDebt5.2 M6.3 M
View BioMarin Pharmaceutical Diagnostics

Selected BioMarin Pharmaceutical Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

BioMarin Pharmaceutical Against Markets

Current Ratings  

BioMarin Pharmaceutical 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 1% 
BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameBioMarin Pharmaceutical Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationCALIFORNIA, U.S.A
Business Address770 Lindaro Street, San Rafael, CA 94901, United States
ExchangeNASDAQ
CIK Number01048477.0
ISINUS09061G1013
CUSIP09061G101
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.biomarin.com
Contact Number415 506 6700
CurrencyUSD - US Dollar

Recommendations

BioMarin Pharmaceutical Analyst Recommendations
Target PriceAdvice# of Analysts
112.59Buy17Odds
BioMarin Pharmaceutical Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
BioMarin Pharmaceutical Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

BioMarin Pharmaceutical Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.29April 27, 2017
BioMarin Pharmaceutical Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate